Biocon Ltd.

NSE: BIOCON | BSE: 532523 | ISIN: INE376G01013 | Industry: Biotechnology
| Mid-range Performer
338.1500 8.10 (2.45%)
NSE Jun 09, 2025 15:57 PM
Volume: 3.3M
 

logo
Biocon Ltd.
15 Nov 2022
338.15
2.45%
Axis Direct
Management indicated that R&D costs will increase in the upcoming quarters which may pose threat to the current margins of the company. We, therefore, recommend a HOLD rating on the stock with a TP of Rs 310/share.
Biocon Ltd. has an average target of 389.25 from 4 brokers.
More from Biocon Ltd.
Recommended